Immuron Limited
IMRN
$1.92
$0.10855.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.30M | 1.34M | 839.30K | 837.60K | 767.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.30M | 1.34M | 839.30K | 837.60K | 767.60K |
| Cost of Revenue | 435.70K | 448.00K | 260.60K | 260.00K | 252.60K |
| Gross Profit | 865.70K | 890.20K | 578.70K | 577.50K | 515.00K |
| SG&A Expenses | 1.26M | 1.29M | 1.29M | 1.28M | 874.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -210.60K | -216.50K | -496.80K | -495.80K | -565.30K |
| Total Operating Expenses | 2.13M | 2.19M | 1.95M | 1.94M | 1.43M |
| Operating Income | -827.20K | -850.50K | -1.11M | -1.11M | -658.20K |
| Income Before Tax | -810.90K | -833.80K | -1.60M | -1.60M | -675.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -810.90K | -833.80K | -1.60M | -1.60M | -675.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -810.90K | -833.80K | -1.60M | -1.60M | -675.60K |
| EBIT | -827.20K | -850.50K | -1.11M | -1.11M | -658.20K |
| EBITDA | -826.20K | -849.60K | -1.11M | -1.10M | -657.00K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 228.53M | 228.53M | 227.92M | 227.92M | 227.80M |
| Average Diluted Shares Outstanding | 228.53M | 228.53M | 227.92M | 227.92M | 227.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |